Log In
BCIQ
Print this Print this
 

FVIII gene therapy (BAX 888)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
Description 
Molecular Target Factor VIII
Mechanism of Action 
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPreclinical
Standard IndicationHemophilia
Indication DetailsTreat hemophilia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today